User profiles for Sébastien Cortaredona
 | CORTAREDONA SébastienAix-Marseille Université, IRD, AP-HM, Service de Santé des Armées (SSA), Vecteurs … Verified email at ird.fr Cited by 3484 |
A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation
P Peretti-Watel, V Seror, S Cortaredona… - The Lancet infectious …, 2020 - thelancet.com
Just a few weeks ago, more than half of the world's population was on lockdown to limit the
spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Scientists are …
spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Scientists are …
The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue
…, P Peretti-Watel, V Seror, S Cortaredona… - Social science & …, 2020 - Elsevier
As Covid-19 spreads across the world, governments turn a hopeful eye towards research
and development of a vaccine against this new disease. But it is one thing to make a vaccine …
and development of a vaccine against this new disease. But it is one thing to make a vaccine …
[HTML][HTML] Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
Background In our institute in Marseille, France, we initiated early and massive screening
for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment with …
for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment with …
[HTML][HTML] Asymptomatic hypoxia in COVID-19 is associated with poor outcome
Objectives Describe and evaluate the outcome of COVID patient without shortness of breath
Design and methods We retrospectively collected data from COVID-19 patients diagnosed …
Design and methods We retrospectively collected data from COVID-19 patients diagnosed …
Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk–benefit balance
Background Vaccine hesitancy (VH) is prominent in France. Objectives: This study aimed to
estimate the prevalence and socio-demographic correlates of VH in sub-groups of the …
estimate the prevalence and socio-demographic correlates of VH in sub-groups of the …
[HTML][HTML] The extra cost of comorbidity: multiple illnesses and the economic burden of non-communicable diseases
S Cortaredona, B Ventelou - BMC medicine, 2017 - Springer
Background The literature offers competing estimates of disease costs, with each study having
its own data and methods. In 2007, the Dutch Center for Public Health Forecasting of the …
its own data and methods. In 2007, the Dutch Center for Public Health Forecasting of the …
[HTML][HTML] Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
Patients with cancer are at higher risk of severe coronavirus infectious disease 2019 (COVID-19),
but the mechanisms underlying virus–host interactions during cancer therapies remain …
but the mechanisms underlying virus–host interactions during cancer therapies remain …
[HTML][HTML] Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
…, N Cassir, L Delorme, S Cortaredona… - Reviews in …, 2021 - imrpress.com
We evaluated the age-specific mortality of unselected adult outpatients infected with SARS-CoV-2
treated early in a dedicated COVID-19 day hospital and we assessed whether the use …
treated early in a dedicated COVID-19 day hospital and we assessed whether the use …
Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: a nationwide cross-sectional study
Background The relations between vaccine hesitancy (VH) and individual socioeconomic
status (SES) vary with context and remain poorly understood. We examined associations …
status (SES) vary with context and remain poorly understood. We examined associations …
[PDF][PDF] Déterminants de l'acceptation individuelle de la vaccination pandémique A (H1N1) 2009 en population adulte française
…, R Flicoteaux, S Cortaredona… - Bulletin …, 2010 - santepubliquefrance.fr
Introduction–Nous avons étudié, fin décembre 2009, l’acceptation individuelle de la
vaccination pandémique contre le nouveau virus grippal A (H1N1) 2009, et les déterminants de …
vaccination pandémique contre le nouveau virus grippal A (H1N1) 2009, et les déterminants de …